Y-mAbs Therapeutics, Inc. Annual Operating Margin in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Y-mAbs Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2023.
  • Y-mAbs Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -33.7 %, a 32.4% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Operating Margin for 2023 was -30.3 %, a 79.2% increase from 2022.
  • Y-mAbs Therapeutics, Inc. annual Operating Margin for 2022 was -145 %, a 56.1% increase from 2021.
  • Y-mAbs Therapeutics, Inc. annual Operating Margin for 2021 was -331 %, a 42.8% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -30.3 +115 +79.2% Jan 1, 2023 Dec 31, 2023
2022 -145 +186 +56.1% Jan 1, 2022 Dec 31, 2022
2021 -331 +247 +42.8% Jan 1, 2021 Dec 31, 2021
2020 -578 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.